Pages that link to "Q36545600"
Jump to navigation
Jump to search
The following pages link to Identification of CD146 as a marker enriched for tumor-propagating capacity reveals targetable pathways in primary human sarcoma (Q36545600):
Displaying 9 items.
- Evaluation of CD146 as Target for Radioimmunotherapy against Osteosarcoma (Q28552916) (← links)
- Mesenchymal Tumors Can Derive from Ng2/Cspg4-Expressing Pericytes with β-Catenin Modulating the Neoplastic Phenotype. (Q37131523) (← links)
- Reduced CD146 expression promotes tumorigenesis and cancer stemness in colorectal cancer through activating Wnt/β-catenin signaling (Q37458003) (← links)
- High-throughput flow cytometry screening of human hepatocellular carcinoma reveals CD146 to be a novel marker of tumor-initiating cells (Q41682711) (← links)
- Cancer stem cell surface markers on normal stem cells (Q42332008) (← links)
- Effects of chondroitin sulfate proteoglycan 4 (NG2/CSPG4) on soft tissue sarcoma growth depend on tumor developmental stage. (Q47340171) (← links)
- High Throughput Flow Cytometry for Cell Surface Profiling (Q47602033) (← links)
- Tracing Tumor Evolution in Sarcoma Reveals Clonal Origin of Advanced Metastasis (Q90061000) (← links)
- Development of mouse models of angiosarcoma driven by p53 (Q92915918) (← links)